US Congress House Bill 5729 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on November 18 2014 - 25% progression, died in committee
Action: 2014-11-21 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Adding Ebola to the FDA Priority Review Voucher Program Act - Amends the Federal Food, Drug, and Cosmetic Act to add filoviruses, a family of viruses that includes the Ebola virus, to the list of tropical diseases under the priority review voucher program, which awards vouchers to sponsors of human drug applications that are approved to prevent or treat tropical diseases. (A voucher entitles the holder to have a future human drug application acted upon by the Food and Drug Administration (FDA) within six months.) Changes the process by which infectious diseases that do not significantly impact developed nations and disproportionately affect poor and marginalized populations can be designated as tropical diseases from rulemaking to order of the Secretary of Health and Human Services (HHS). Allows priority review vouchers to be transferred between sponsors of human drug applications any number of times. Reduces from 365 days to 90 days the advance notice required before submitting a human drug application subject to a priority review voucher.

Adding Ebola to the FDA Priority Review Voucher Program Act

Sen. Marsha Blackburn [R-TN]	Rep. G. Butterfield [D-NC]	Rep. Charles Fleischmann [R-TN]	Rep. Gene Green [D-TX]
Rep. Michael McCaul [R-TX]

Date	Chamber	Action
2014-11-21	House	Referred to the Subcommittee on Health.
2014-11-18	House	Referred to the House Committee on Energy and Commerce.

SB2917 (Same As) 2014-12-16 - Became Public Law No: 113-233.

Type	Source
Summary	https://www.congress.gov/bill/113th-congress/house-bill/5729/all-info
Text	https://www.congress.gov/113/bills/hr5729/BILLS-113hr5729ih.pdf